Diligence memo · auto-generated · as of July 2, 2026

ProTom International, Inc.

ProTom International, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

ProTom International, Inc. operates in Other Health Care, based in FLOWER MOUND.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

ProTom International, Inc. has raised $1.8M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $936K on 2009-04-30.

Most recent recorded round closed around 2012-08-10.

Valuation (modeled)modeled

Provath models ProTom International, Inc. at approximately $27M (range $539K–$301M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.87× the median modeled value of Pre-Seed Other Health Care companies in 2010–2012 (351 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 39 months.

Last raise 13.9 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 45% of Other Health Care peers (5377 compared).

Modeled value ranks above 54% of those peers.

Closest niche peers: Chrysallis, Inc., RefillDRS, LLC, Ageology LLC, Great Lakes Healthcare Fund I, LLC, CreateHealth, Inc..

Peoplefiled

11 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.